Metabolic syndrome and diabetes type 2 are on the increase in the developed world. EU funding is being used to research the role of gut microbes in the control of obesity and related metabolic diseases, including non-alcoholic fatty liver disease (NAFLD).
Further information: cordis.europa.eu